Merja Haikola
Comptroller/Controller/Auditor chez BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Profil
Merja Haikola is currently the Accountable Director at BBS-Bioactive Bone Substitutes Plc since 2023.
Previously, she worked as a Principal at AKELA Pharma Oy from 1988 to 2003, at Leiras Oy as a Principal, and at Cancer Targeting Technologies Oy as a Principal from 2003 to 2006.
Postes actifs de Merja Haikola
| Sociétés | Poste | Début |
|---|---|---|
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Comptroller/Controller/Auditor | 23/12/2023 |
Anciens postes connus de Merja Haikola
| Sociétés | Poste | Fin |
|---|---|---|
Cancer Targeting Technologies Oy
 Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | Corporate Officer/Principal | 01/01/2006 |
AKELA Pharma Oy
 AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Corporate Officer/Principal | 01/01/2003 |
Leiras Oy
 Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
| Entreprise privées | 3 |
|---|---|
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Health Technology |
Cancer Targeting Technologies Oy
Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland | Health Technology |
Leiras Oy
Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
